A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long ...

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...

It's unclear whether the small increased risks of type 2 diabetes highlighted in this red-meat research hold any true ...

A door-to-door survey conducted between January and August has revealed alarming levels of diabetes and hypertension cases ...

Researchers discovered that IBD significantly increases the risk of developing T1D, and this association works both ways, ...

Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...